News Center

Home page

Peak Report

News reports

The company asked to continue to do a good job in the prevention and control of the new coronary pneumonia epidemic.

Release time:

2021-01-11

war "epidemic" has not yet been successfully prevented and controlled still need to work

company requirements to continue to do a good job in the prevention and control of the new coronary pneumonia epidemic

this newspaper company recently issued a notice, requiring all units to continue to do a good job in the prevention and control of the new coronary pneumonia epidemic.

The recent global neo-coronary pneumonia epidemic has mutated, and local cases and asymptomatic infections have been found in many parts of the country, making the epidemic prevention and control situation more complex. As the Spring Festival approaches, people move and gather more frequently around the country, bringing many uncertainties to the prevention and control of the epidemic. To this end, the central and local party committees and governments at all levels have held special meetings to make arrangements for the prevention and control of the recent new coronary pneumonia epidemic. In order to fully and effectively implement the spirit of the superior's instructions on epidemic prevention and control, effectively do a good job in the company's epidemic prevention and control work, and ensure the health and safety of employees, the company specially puts forward requirements on relevant precautions:

Keep in mind the main responsibility and implement the prevention and control requirements. All units should fully understand the complexity of the current epidemic prevention and control situation, assume the main responsibility for epidemic prevention and control, and conscientiously and strictly implement various prevention and control measures in accordance with the requirements of the epidemic prevention and control responsibility letter, in line with the sense of responsibility for the life and health of employees, the enterprise and the society and the overall situation.

Strengthen workplace access and employee health management. Continue to do a good job in the temperature measurement and registration of employees entering the company at work. Foreign staff shall strictly measure the temperature, check the health code and register. If symptoms such as fever, cough and chest tightness are found, they shall be advised to seek medical treatment in time. Express delivery and take-out personnel are not allowed to enter the office and production areas.

Strengthen staff health education and develop good health and epidemic prevention habits. Strengthen the publicity of health and epidemic prevention knowledge, and educate employees on epidemic prevention and control; advocate scientific wearing of masks, sorting and putting of garbage, timely disinfection of foreign items, avoiding going to crowded places, maintaining a safe social distance, washing hands frequently, frequent ventilation and other work and living habits.

Strengthen the internal public health work of the company, and do a good job in the production sites and public places of the enterprise.

Strictly enforce food hygiene regulations to eliminate food safety hazards. Strengthen the management of canteen procurement, cleaning and processing, and cooking; Strictly disinfect the canteen environment and tableware; Continue to implement the system of dividing meals by time, and remind employees to keep a certain safe distance when eating in the canteen.

Reasonable arrangements for travel, orderly control of personnel flow. Strengthen mission work and avoid travel to medium-high risk areas. Employees who must travel to medium and high-risk areas due to work relations or work abroad in relevant areas must strictly carry out nucleic acid tests after returning to the unit, and the test results are normal before going to work. The nucleic acid test expenses shall be reimbursed by the unit to which they belong.

Reduce all kinds of activities and reduce personnel gathering. Reasonably arrange all kinds of meetings at the end of the year and the beginning of the year, and organize them online or video as much as possible; Cancel unnecessary dinners and parties, and strictly control the scale of various activities.

In addition to continuously and conscientiously implementing the internal epidemic prevention and control requirements of the enterprise, in view of the frequent movement of personnel and the increase in the number of gatherings of relatives and friends before and after the Spring Festival, the company also specially advocated in the notice that employees should stay in the place where the unit is located for the holidays, reduce going out, adopt WeChat, video and other online New Year greetings as far as possible, avoid gatherings in crowded and poorly ventilated places, and prevent the epidemic risks as possible, it is hoped that employees will pay attention to the epidemic information through authoritative channels, resolutely resist all kinds of online rumors, do not spread rumors, do not believe rumors, do not spread rumors, and all employees will work together to do a good job in the company's epidemic prevention and control work. (this newspaper reporter)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页